EMEA-003240-PIP01-22
Key facts
| Active substance |
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0387/2022
|
| PIP number |
EMEA-003240-PIP01-22
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Teva B.V.
Email: MedAffGenTevaEurope@tevapharm.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|